Jerry Moran actually said...

"In my view, this hearing was what a congressional hearing in most instances should be, an opportunity to be educated and to learn."

"The FDA's role in the drug approval process is critical to expanding the pharmaceutical market and driving down costs for consumers."

"I also mentioned that you were able--I know this is not a generic drug, but we were talking about Duchenne and the muscular dystrophy drug."

"Is there a common denominator for drug companies who are required to submit additional information during the approval process?"